Cross-intolerance to imatinib, dasatinib and nilotinib therapy in a patient with chronic myeloid leukaemia

被引：2
|
作者：
Novitzky-Basso, Igor [1 ]
Craddock, Charles [1 ]
机构：
[1] Univ Hosp Birmingham, Ctr Clin Haematol, Birmingham B15 2TH, W Midlands, England
来源：
EUROPEAN JOURNAL OF HAEMATOLOGY | 2011年 / 86卷 / 06期
关键词：
CYTOGENETIC RESPONSES;
D O I：
10.1111/j.1600-0609.2011.01603.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：548 / 549
页数：2
相关论文
共 50 条
  • [41] Dasatinib-induced panniculitis in a patient with chronic myeloid leukaemia
    Yusuke Nagasawa
    Shin Iinuma
    Mizue Fujii
    Kyoko Kanno
    Masaru Honma
    Sayaka Yuzawa
    Akemi Ishida-Yamamoto
    European Journal of Dermatology, 2021, 31 : 87 - 88
  • [42] Dasatinib causing Intracerebral Bleeding in a Patient with Chronic Myeloid Leukaemia
    Rathod, Santosh Govind
    Khan, Afaq Ahmad
    Geelani, Sajad Ahmed
    Roshan, Reshma
    Bhat, Javid Rasool
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (06)
  • [43] Dasatinib-induced colitis in a patient with chronic myeloid leukaemia
    Gluch, Alexander Edmund
    Subhaharan, Deloshaan
    Pillai, Sooraj
    Ramaswamy, Pradeep Kakkadasam
    BMJ CASE REPORTS, 2025, 18 (01)
  • [44] Medication adherence among adults prescribed imatinib, dasatinib, or nilotinib for the treatment of chronic myeloid leukemia
    Anderson, Kristin R.
    Chambers, Carole R.
    Lam, Nadine
    Yau, Patrick S.
    Cusano, Frances
    Savoie, M. Lynn
    Sheikh, Naureen
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2015, 21 (01) : 19 - 25
  • [45] Resolution of platelet function defects with imatinib therapy in a patient with chronic myeloid leukaemia in chronic phase
    Ng, Ashley P.
    Servadei, Patricia
    Tuckfield, Annabel
    Friedhuber, Anna
    Grigg, Andrew
    BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (01) : 81 - 83
  • [46] Effect of prior therapy with Nilotinib or Dasatinib on the outcome after allogeneic stem cell transplantation for patients with chronic myeloid leukaemia
    Schleuning, M.
    Olavarria, E.
    Scholten, M.
    van Biezen, A.
    Michallet, M.
    Nagler, A.
    Hochhaus, A.
    Grigg, A.
    Silver, R.
    Schuld, P.
    Niederwieser, D.
    de Witte, T.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S32 - S32
  • [47] Effect of prior therapy with nilotinib or dasatinib on the outcome after allogeneic stem cell transplantation for patients with chronic myeloid leukaemia
    Schleuning, M.
    Scholten, M.
    van Biezen, A.
    Nagler, A.
    Apperley, J.
    Michallet, M.
    Grigg, A.
    Silver, R.
    Niederwieser, D.
    De Witte, T.
    Olavarria, E.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S240 - S240
  • [48] Efficacy of nilotinib in a patient in late chronic phase CML, intolerant to imatinib and resistant to dasatinib
    Usala, Emilio
    CLINICAL MANAGEMENT ISSUES, 2011, 5 : 27 - 30
  • [49] Delayed resistance to imatinib after 16 years of therapy in a patient with chronic myeloid leukaemia
    Kaur, Upinder
    Gambhir, Indrajeet Singh
    Khare, Vibhu Ranjan
    Singh, Amit
    Chakrabarti, Sankha Shubhra
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (01) : E51 - E53
  • [50] More about Imatinib and Nilotinib Combination Therapy in Chronic Myeloid Leukemia
    Gomez-Almaguer, David
    Tarin-Arzaga, Luz
    Cantu-Rodriguez, Olga
    Ceballos-Lopez, Adrian
    ACTA HAEMATOLOGICA, 2013, 129 (01) : 18 - 19
12345